Public Forum: From Discoveries to Commercialization—August 5

Stem Cell Biology & Translational Medicine

pf03OTTED had the first of the “From Discoveries to Commercialization” series, co-sponsored by GE Healthcare Life Sciences on August 5, 2015. The theme was Stem Cell Biology and Translational Medicine. In the morning session, Dr. Hiromitsu Nakauchi, a professor of Stanford University and renowned stem cell biologist, and Dr. Norio Nakatsuji, a professor of Kyoto University and founder of ReproCELL, discussed potential applications of stem cells in medical therapies and commercialization potential of stem cell research. At the afternoon’s tech transfer forum, four University of Hawai`i researchers presented their research and had an open discussion on potential commercialization plans. The event was well received. Any additional feedback can be emailed to otted@hawaii.edu.

Greg Titus, GE Life Sciences Dr. Hiromitsu Nakauchi, Stanford School of Medicine Dr. Vernon Oi, Bill Richardson, Dr. Norio Nakatsuji
Dr. Norio Nakatsuji, Kyoto University & ReproCELL pf02 pf08
Su Jun Lim-Higbie, UH OTTED pf04 pf09

Panelists

Vernon Oi, Ph.D.
Co-inventor of the process for generating functional antibodies, Stanford’s second highest royalty producer

Norio Nakatsuji, D.Sc.
Professor of Kyoto University and founder of ReproCELL, a leading stem cell company in Japan

Hiromitsu Nakauchi, M.D., Ph.D.
Professor of Stanford and renowned stem cell biologist

Bill Richardson, J.D.
Director of OTTED, seasoned venture capitalist and lecturer at School of Law

UH presenters

Monika Ward, Ph.D.
Institute for Biogenesis Research, JABSOM

Stefan Moisyadi, Ph.D.
Institute for Biogenesis Research, JABSOM

Pietro Bertino, Ph.D.
Cell and Molecular Biology, JABSOM

Aaron Rose, Ph.D.
Cell and Molecular Biology, JABSOM & Bio-Logic Hawaii